Pricing Log in Create free account

Axsome Therapeutics, Inc. (AXSM) vs Oruka Therapeutics, Inc. (ORKA)

Axsome Therapeutics, Inc. and Oruka Therapeutics, Inc. are both Biotechnology companies. Axsome Therapeutics, Inc. and Oruka Therapeutics, Inc. are of similar size ($6.8B and $6.4B). Oruka Therapeutics, Inc. has the higher net margin (0.00% vs −18.2%) and the lower return on invested capital (−40.2% vs 0.00%). Across the 14 metrics below, Oruka Therapeutics, Inc. leads on 10 and Axsome Therapeutics, Inc. on 4.

Valuation

Metric AXSM ORKA Biotechnology median
P/E n/m n/m 10.26
P/S 7.83 n/m 9.18
P/B 64.25 5.47 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 7.61 n/m 8.98
Earnings yield (2.37%) (2.19%) (34.89%)
Free cash flow yield (1.22%) (1.66%) (24.52%)

Profitability

Metric AXSM ORKA Biotechnology median
Gross margin 93.25% 0.00% 65.16%
Operating margin (17.45%) 0.00% 0.00%
Net margin (18.18%) 0.00% 0.00%
Free cash flow margin (9.55%) 0.00% 0.00%
Return on equity (175.59%) (18.30%) (50.12%)
Return on assets (21.03%) (17.76%) (45.60%)
Return on invested capital 0.00% (40.22%) 0.00%

Growth

Metric AXSM ORKA Biotechnology median
Revenue growth (TTM) 54.16% — 6.26%
EPS growth (last fiscal year) 38.56% 52.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AXSM ORKA Biotechnology median
Debt to equity 1.21 0.00 0.00
Current ratio 1.42 38.51 4.89
Net debt to EBITDA 1.29 2.65 1.01

Dividend

Metric AXSM ORKA Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric AXSM ORKA Biotechnology median
Market cap 6.83b 6.36b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack